Summary

for people ages 18 years and up (full criteria)
healthy people welcome
at UC Davis
study started
estimated completion:

Description

Summary

There is a pressing national need to provide higher-quality, more effectively accessible language interpretation services to improve the health outcomes of Americans who have limited English proficiency (LEP). This project addresses a critical component of this problem: The need to improve access to high quality, mental health services for diverse populations by improving the flow of clinical work across care settings (primary care and specialty care) through the use of innovative online asynchronous methods of language interpretation and clinical communication. The investigators are conducting a two phase study. The first phase is completed and involved developing and testing the interpreting tool. The second phase of the research is a clinical trial to compare two methods of cross-language psychiatric assessment.

Official Title

A Clinical Trial to Validate an Automated Online Language Interpreting Tool With Hispanic Patients Who Have Limited English Proficiency - Phase Two.

Details

The investigators propose to develop and test a novel automated asynchronous interpretation tool. The proposed project builds on previous research, piloting the automated asynchronous interpretation tool. This 5-year project will be conducted in two phases. In Phase 1 the investigators iteratively evaluate and refine the automated asynchronous interpretation tool already developed in prior studies. In Phase 2, the investigators evaluate this tool using a two-group randomized cross-over trial. Investigators compare:

  • Method A (current gold standard of in-person real-time interpreting practice). A Spanish-speaking patient is diagnostically assessed in-person by an English-speaking psychiatrist through a Spanish-speaking interpreter.
  • Method B (comparative practice - ATP). A Spanish-speaking patient is interviewed in Spanish by a trained mental health interviewer. The interview is recorded in real time, translated into English using the automatic interpretation tool and adding sub-titles to the video file, and sent to an English-speaking psychiatrist to asynchronously — that is, at a later time — review the video and make a diagnosis.

All patients will undergo evaluation by both methods. Half of the patients will be randomized to be assessed by Method A first, followed by Method B and half to be assessed by Method B first, followed by Method A. The specific aims of the study are :

  • Aim 1: To iteratively evaluate and refine the automated asynchronous interpretation tool already developed in prior studies.
  • Aim 2: To compare patient satisfaction of Method A vs. Method B.
  • Aim 3: To compare the diagnostic accuracy and psychiatrist inter-rater reliability of Method A vs. Method B and demonstrate psychiatrist inter-rater reliability for Method B.
  • Aim 4: To compare the interview and language interpretation quality and accuracy of Method A vs. Method B.
  • Aim 5: To evaluate the diagnostic accuracy of facial recognition software compared with the psychiatrists

Keywords

Mood Disorder Anxiety Disorder Substance Use Disorder Chronic Medical Condition Telepsychiatry AsynchronousTelepsychiatry Automated Translation Disease Anxiety Disorders Mood Disorders Substance-Related Disorders Active comparator: Human interpreter Intervention: Asynchronous Telepsychiatry

Eligibility

You can join if…

Open to people ages 18 years and up

Inclusion Criteria: Hispanic patients with significant Limited English proficiency (LEP)

  • aged 18 or older
  • diagnosis of a mood disorder, anxiety disorder, or substance/alcohol abuse disorder(s)
  • Diagnosis of a chronic medical condition
  • referred by PCP or self-referral with PCP informed

You CAN'T join if...

Criteria:

  • less than 18 years
  • imminent suicidal ideation and/or plans
  • immediate violent intentions or plans
  • significant cognitive deficits
  • patient who's PCP recommends not participating.

Location

  • UC Davis Medical Center accepting new patients
    Sacramento California 95817 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
ID
NCT03538860
Study Type
Interventional
Last Updated